Macimorelin as a treatment for ALS/MND (2021–2023)

Grant type:
Aeterna Zentaris GmbH
Researchers:
  • Associate Professor
    School of Biomedical Sciences
    Faculty of Medicine
    Associate Professor
    School of Biomedical Sciences
    Faculty of Medicine
  • Principal Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
    Principal Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Aeterna Zentaris GmbH